Protibea Therapeutics, Inc. — Form D
Protibea Therapeutics, Inc. of GEORGETOWN, TX, a company, filed a Form D exempt-offering notice with the SEC on 2021-05-28. The offering totals $1.2M, of which $770K was reported sold. Industry: Other.
Offering
- Filed: 2021-05-28
- Form: D
- Accession: 0001864104-21-000002
- Industry: Other
- Exemptions: 06b
- Total offering: $1.2M
- Amount sold: $770K
- Remaining: $430K
- Minimum investment: $75K
- Investors: 8
- Date of first sale: 2021-05-10
- Revenue range: Decline to Disclose
- SEC file number: 021-401127
Issuer
- Name: Protibea Therapeutics, Inc.
- CIK: 0001864104
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 1108 LEGACY CROSSING, GEORGETOWN, TX, 78628
- Phone: 915-490-0715
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| William Mann Chamberlin | Director | Georgetown, TX |
| Yu Mann Ge | Director | Georgetown, TX |
| William Mann Chamberlin | Executive Officer | Georgetown, TX |
| Yu Mann Ge | Executive Officer | Georgetown, TX |
| Jim Moriarty | Director | Georgetown, TX |
| Jim Moriarty | Executive Officer | Georgetown, TX |
| Yu Ge | Director | Georgetown, TX |
| William Chamberlin | Director | Georgetown, TX |
| William Chamberlin | Executive Officer | Georgetown, TX |
| Harry Oken | Director | Georgetown, TX |
Other filings by this issuer (1)
More